Sonnet BioTherapeutics Holdings, Inc. Annual Return On Assets in % from 2012 to 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2024.
  • Sonnet BioTherapeutics Holdings, Inc. Return On Assets for the quarter ending December 31, 2024 was -174 %, a 2.71% decline year-over-year.
  • Sonnet BioTherapeutics Holdings, Inc. annual Return On Assets for 2024 was -150 %, a 32.8% increase from 2023.
  • Sonnet BioTherapeutics Holdings, Inc. annual Return On Assets for 2023 was -223 %, a 7.72% increase from 2022.
  • Sonnet BioTherapeutics Holdings, Inc. annual Return On Assets for 2022 was -242 %, a 13.4% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -150 +73.3 +32.8% Oct 1, 2023 Sep 30, 2024
2023 -223 +18.7 +7.72% Oct 1, 2022 Sep 30, 2023
2022 -242 -28.7 -13.4% Oct 1, 2021 Sep 30, 2022
2021 -213 -83.5 -64.3% Oct 1, 2020 Sep 30, 2021
2020 -130 -73.2 -129% Oct 1, 2019 Sep 30, 2020
2019 -56.7 -33.7 -146% Jan 1, 2019 Dec 31, 2019
2018 -23 -1.8 -8.48% Jan 1, 2018 Dec 31, 2018
2017 -21.2 +3.71 +14.9% Jan 1, 2017 Dec 31, 2017
2016 -24.9 +3.46 +12.2% Jan 1, 2016 Dec 31, 2016
2015 -28.4 -8.88 -45.5% Jan 1, 2015 Dec 31, 2015
2014 -19.5 +20.7 +51.5% Jan 1, 2014 Dec 31, 2014
2013 -40.3 +1.37 +3.29% Jan 1, 2013 Dec 31, 2013
2012 -41.6 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.